Keyt Bruce 4
4 · IGM Biosciences, Inc. · Filed Jul 23, 2024
Insider Transaction Report
Form 4
Keyt Bruce
Chief Scientific Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2024-07-19−50,000→ 0 totalExercise: $91.50Exp: 2031-02-19→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-07-19−75,000→ 0 totalExercise: $40.27Exp: 2030-02-05→ Common Stock (75,000 underlying) - Award
Common Stock
2024-07-19+43,888→ 241,657 total - Award
Common Stock
2024-07-19+2,778→ 244,435 total
Holdings
- 4,039(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on July 19, 2025 and one-eighth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
- [F2]Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 75,000 shares and 50,000 shares of the Issuer's Common Stock and in exchange issued aggregate RSU grants of 43,888 shares and 2,778 shares.
- [F3]These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on January 19, 2026 and one-twelfth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
- [F4]The shares are held directly by the Reporting Person's spouse.